- Home
- FNKO vs TERN Comparison
FNKO vs TERN Comparison
Compare FNKO & TERN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- FNKO
- TERN
- Stock Information
- Founded
- FNKO 2017
- TERN 2017
- Country
- FNKO United States
- TERN United States
- Employees
- FNKO N/A
- TERN N/A
- Industry
- FNKO Recreational Games/Products/Toys
- TERN Biotechnology: Pharmaceutical Preparations
- Sector
- FNKO Consumer Discretionary
- TERN Health Care
- Exchange
- FNKO Nasdaq
- TERN Nasdaq
- Market Cap
- FNKO 666.7M
- TERN 586.0M
- IPO Year
- FNKO 2017
- TERN 2021
- Fundamental
- Price
- FNKO $11.39
- TERN $5.88
- Analyst Decision
- FNKO Strong Buy
- TERN Buy
- Analyst Count
- FNKO 3
- TERN 6
- Target Price
- FNKO $13.83
- TERN $16.42
- AVG Volume (30 Days)
- FNKO 666.4K
- TERN 1.2M
- Earning Date
- FNKO 11-07-2024
- TERN 11-12-2024
- Dividend Yield
- FNKO N/A
- TERN N/A
- EPS Growth
- FNKO N/A
- TERN N/A
- EPS
- FNKO N/A
- TERN N/A
- Revenue
- FNKO $1,047,357,000.00
- TERN N/A
- Revenue This Year
- FNKO N/A
- TERN N/A
- Revenue Next Year
- FNKO $7.50
- TERN N/A
- P/E Ratio
- FNKO N/A
- TERN N/A
- Revenue Growth
- FNKO N/A
- TERN N/A
- 52 Week Low
- FNKO $5.36
- TERN $3.86
- 52 Week High
- FNKO $12.61
- TERN $11.40
- Technical
- Relative Strength Index (RSI)
- FNKO 54.48
- TERN 35.40
- Support Level
- FNKO $10.10
- TERN $5.46
- Resistance Level
- FNKO $10.60
- TERN $7.53
- Average True Range (ATR)
- FNKO 0.53
- TERN 0.43
- MACD
- FNKO 0.07
- TERN -0.05
- Stochastic Oscillator
- FNKO 61.78
- TERN 19.35
About FNKO Funko Inc.
Funko Inc is an us-based pop culture consumer products company. It creates whimsical, fun, and different products that enable the customer to express their affinity for their favorite through the movie, TV show, video game, musician, or sports team. The company's current products are principally figures, fashion accessories, apparel, plush products, accessories, homewares, and NFTs. The company sells its products through a diverse network of retail customers across multiple retail channels, including specialty retailers, mass-market retailers, and e-commerce sites. The company generates the majority of its revenue from the core collectibles products.
About TERN Terns Pharmaceuticals Inc.
Terns Pharmaceuticals Inc is a clinical-stage biopharmaceutical company. The company is developing a portfolio of small-molecule single-agent and combination therapy candidates for the treatment of non-alcoholic steatohepatitis, NASH, and other chronic liver diseases.